Jobs appears closer to returning to work at Apple

June 24, 2009 By JANET BLAKE , Associated Press Writer
FILE - In this Sept. 9, 2009 file photo, shows Apple CEO Steve Jobs smiling at a conference in San Francisco. A Memphis, Tenn., hospital is confirming that Apple founder Steve Jobs received a liver transplant and that he has an "excellent prognosis." Dr. James D. Eason made the announcement Tuesday June 23, 2009 on the hospital's Web site. He is program director at Methodist University Hospital Transplant Institute and chief of transplantation. (AP Photo/Paul Sakuma, file)

(AP) -- Apple co-founder and CEO Steve Jobs appears to be a step closer to returning to work, as a doctor gave him an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital.

"He received a liver transplant because he was ... the sickest patient on the waiting list at the time a became available," Dr. James D. Eason, chief of transplantation at Methodist University Hospital Transplant Institute in Memphis, said in a statement late Tuesday. "Mr. Jobs is now recovering well and has an excellent prognosis."

Eason said in a news release posted on the hospital's Web site that when Jobs received the transplant, he was in end-stage .

The doctor made the disclosure with Jobs' permission. Jobs has been on a medical leave since January.

Eason did not reveal when the operation took place, citing patient privacy. However, The Wall Street Journal reported it was two months ago.

did not confirm the newspaper's report, and has said only that Jobs is looking forward to returning to Apple - which he started in 1976 - at the end of June.

Eason said the hospital could not reveal further information on the specifics of the transplant.

"That's all that we are giving out at this time," hospital spokeswoman Ruth Ann Hale told The Associated Press.

Wall Street has grappled with the implications of Jobs' health since August 2004, when investors learned the CEO had kept a cancer diagnosis secret until after he underwent surgery. The company's past silence on matters of Jobs' health made shareholders jittery when he appeared increasingly, even alarmingly, thin last year.

Investors sent the stock tumbling 5 percent to its lowest point in a year on a rumor last October that Jobs had suffered a heart attack.

Then shares slipped 2 percent in December when Apple said that Jobs would not speak as usual the next month at the annual Macworld conference, then bounced up 4 percent on Jan. 5 when Jobs explained his weight loss as a treatable hormone imbalance. They sank 7 percent a week later after Apple said he would be taking six months off because his medical problems were more complex than he initially thought.

Since then, Wall Street's whiplash has had time to heal, especially because Apple's stock has weathered the recession better than those of most of its competitors.

Cupertino, California-based Apple put Tim Cook, its chief operating officer, at the helm during Jobs' absence.

Apple shares were up 99 cents at $135 in premarket trading Wednesday. They are up more than 70 percent from their 52-week low of $78.20 on Jan. 20.

---

On the Net:

http://www.methodisthealth.org

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Apple 2Q profit gains 15 percent, beats Street

Related Stories

Apple 2Q profit gains 15 percent, beats Street

April 22, 2009

(AP) -- Strong sales of the iPhone helped Apple Inc. lift its quarterly profit 15 percent, well ahead of Wall Street's expectations Wednesday despite the global economic downturn.

Apple CEO gets liver transplant: report

June 20, 2009

Apple chief executive Steve Jobs, on medical leave since January for treatment of an undisclosed condition, received a liver transplant about two months ago in Tennessee, The Wall Street Journal reported Saturday.

Apple fans are prepared for a part-time Jobs

June 22, 2009

(AP) -- Five and a half months ago, word that Steve Jobs would only work part-time as he recovered from a liver transplant would have sent investors into a selling frenzy, so closely linked was Apple's charismatic co-founder ...

Business 101: Must Apple discuss CEO Jobs' health?

June 22, 2009

(AP) -- This week, Apple Inc. wasn't shy about touting the sales of its latest mobile device. But the company didn't say anything confirming reports from over the weekend that co-founder and CEO Steve Jobs had a liver transplant ...

Recommended for you

Team develops targeted drug delivery to lung

September 2, 2015

Researchers from Columbia Engineering and Columbia University Medical Center (CUMC) have developed a new method that can target delivery of very small volumes of drugs into the lung. Their approach, in which micro-liters ...

Not another new phone! But Nextbit's Robin is smarter

September 2, 2015

San Francisco-based Nextbit wants you to meet Robin, which they consider as the smarter smartphone. Their premise is that no one is making a smart smartphone; when you get so big it's hard to see the forest through the trees. ...

Team creates functional ultrathin solar cells

August 27, 2015

(Phys.org)—A team of researchers with Johannes Kepler University Linz in Austria has developed an ultrathin solar cell for use in lightweight and flexible applications. In their paper published in the journal Nature Materials, ...

Magnetic fields provide a new way to communicate wirelessly

September 1, 2015

Electrical engineers at the University of California, San Diego demonstrated a new wireless communication technique that works by sending magnetic signals through the human body. The new technology could offer a lower power ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.